MTVA
MetaVia Inc.
Biotechnology
Market Cap$7M
5Y Perf.-45.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
MTVA vs MVIS
Revenue, margins, valuation, and 5-year total return — side by side.
MVIS
MicroVision, Inc.
Hardware, Equipment & Parts
Market Cap$201M
5Y Perf.-27.2%
MTVA vs MVIS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | MTVA | MVIS |
|---|---|---|
| Industry | Biotechnology | Hardware, Equipment & Parts |
| Market Cap | $7M | $201M |
| Revenue (TTM) | $0.00 | $1M |
| Net Income (TTM) | $-16M | $-95M |
| Gross Margin | — | -14.4% |
| Operating Margin | — | -57.4% |
| Total Debt | $136K | $37M |
| Cash & Equiv. | $16M | $32M |
MTVA vs MVIS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
MTVA
MVIS
| Stock | Nov 24 | May 26 | Return |
|---|---|---|---|
| MetaVia Inc. (MTVA) | 100 | 54.9 | -45.1% |
| MicroVision, Inc. (MVIS) | 100 | 72.8 | -27.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MTVA vs MVIS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MTVA leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. MicroVision, Inc. is the stronger pick specifically for operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
MTVA
MetaVia Inc.
The Income Pick
MTVA carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 0.67
- -44.7% 10Y total return vs MVIS's -65.7%
- Lower volatility, beta 0.67, Low D/E 1.7%, current ratio 1.94x
Best for: income & stability and long-term compounding
MVIS
MicroVision, Inc.
The Growth Play
MVIS is the clearest fit if your priority is growth exposure.
- Rev growth -74.3%, EPS growth 23.9%, 3Y rev CAGR 22.1%
- -74.3% ROA vs MTVA's -105.3%
Best for: growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | MTVA | 41.6% revenue growth vs MVIS's -74.3% |
| Quality / Margins | MTVA | 5.7% margin vs MVIS's -78.6% |
| Stability / Safety | MTVA | Beta 0.67 vs MVIS's 2.61, lower leverage |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | MTVA | +89.0% vs MVIS's -42.0% |
| Efficiency (ROA) | MVIS | -74.3% ROA vs MTVA's -105.3% |
MTVA vs MVIS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
MTVA vs MVIS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLMTVALAGGINGMVIS
MVISMicroVision, Inc.
1leads
MTVAMetaVia Inc.
2leads
6 Total Categories
CATEGORYLEADERvs MVISMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
MTVA1/1
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
MVIS4/7
Total Returns1Y, 3Y, 5Y total returns with dividends
MTVA5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
MTVA leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
MVIS and MTVA operate at a comparable scale, with $1M and $0 in trailing revenue.
| Metric | MTVAMetaVia Inc. | MVISMicroVision, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $0 | $1M |
| EBITDAEarnings before interest/tax | -$17M | -$64M |
| Net IncomeAfter-tax profit | -$16M | -$95M |
| Free Cash FlowCash after capex | -$16M | -$59M |
| Gross MarginGross profit ÷ Revenue | — | -14.4% |
| Operating MarginEBIT ÷ Revenue | — | -57.4% |
| Net MarginNet income ÷ Revenue | — | -78.6% |
| FCF MarginFCF ÷ Revenue | — | -49.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -86.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +74.5% | +14.3% |
MTVA leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
Evenly matched — MTVA and MVIS each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | MTVAMetaVia Inc. | MVISMicroVision, Inc. |
|---|---|---|
| Market CapShares × price | $7M | $201M |
| Enterprise ValueMkt cap + debt − cash | -$9M | $205M |
| Trailing P/EPrice ÷ TTM EPS | -0.04x | -1.87x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 166.25x |
| Price / BookPrice ÷ Book value/share | 0.12x | 3.22x |
| Price / FCFMarket cap ÷ FCF | — | — |
Evenly matched — MTVA and MVIS each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
MVIS leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
MVIS delivers a -137.4% return on equity — every $100 of shareholder capital generates $-137 in annual profit, vs $-2 for MTVA. MTVA carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to MVIS's 0.66x. On the Piotroski fundamental quality scale (0–9), MVIS scores 3/9 vs MTVA's 2/9, reflecting mixed financial health.
| Metric | MTVAMetaVia Inc. | MVISMicroVision, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | -2.3% | -137.4% |
| ROA (TTM)Return on assets | -105.3% | -74.3% |
| ROICReturn on invested capital | — | -98.3% |
| ROCEReturn on capital employed | -2.3% | -93.6% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.02x | 0.66x |
| Net DebtTotal debt minus cash | -$16M | $4M |
| Cash & Equiv.Liquid assets | $16M | $32M |
| Total DebtShort + long-term debt | $136,000 | $37M |
| Interest CoverageEBIT ÷ Interest expense | — | -3.54x |
MVIS leads this category, winning 4 of 7 comparable metrics.
Total Returns (Dividends Reinvested)
MTVA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MTVA five years ago would be worth $5,534 today (with dividends reinvested), compared to $468 for MVIS. Over the past 12 months, MTVA leads with a +89.0% total return vs MVIS's -42.0%. The 3-year compound annual growth rate (CAGR) favors MTVA at -17.9% vs MVIS's -34.5% — a key indicator of consistent wealth creation.
| Metric | MTVAMetaVia Inc. | MVISMicroVision, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -85.4% | -26.4% |
| 1-Year ReturnPast 12 months | +89.0% | -42.0% |
| 3-Year ReturnCumulative with dividends | -44.7% | -71.9% |
| 5-Year ReturnCumulative with dividends | -44.7% | -95.3% |
| 10-Year ReturnCumulative with dividends | -44.7% | -65.7% |
| CAGR (3Y)Annualised 3-year return | -17.9% | -34.5% |
MTVA leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — MTVA and MVIS each lead in 1 of 2 comparable metrics.
Risk & Volatility
MTVA is the less volatile stock with a 0.67 beta — it tends to amplify market swings less than MVIS's 2.61 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MVIS currently trades 37.9% from its 52-week high vs MTVA's 10.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | MTVAMetaVia Inc. | MVISMicroVision, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.67x | 2.61x |
| 52-Week HighHighest price in past year | $13.42 | $1.73 |
| 52-Week LowLowest price in past year | $0.55 | $0.51 |
| % of 52W HighCurrent price vs 52-week peak | +10.4% | +37.9% |
| RSI (14)Momentum oscillator 0–100 | 44.9 | 52.7 |
| Avg Volume (50D)Average daily shares traded | 134K | 5.3M |
Evenly matched — MTVA and MVIS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | MTVAMetaVia Inc. | MVISMicroVision, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $5.00 |
| # AnalystsCovering analysts | — | 7 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
MTVA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). MVIS leads in 1 (Profitability & Efficiency). 2 tied.
Best OverallMetaVia Inc. (MTVA)Leads 2 of 6 categories
Loading custom metrics...
MTVA vs MVIS: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is MTVA or MVIS a better buy right now?
Analysts rate MicroVision, Inc.
(MVIS) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — MTVA or MVIS?
Over the past 5 years, MetaVia Inc.
(MTVA) delivered a total return of -44. 7%, compared to -95. 3% for MicroVision, Inc. (MVIS). Over 10 years, the gap is even starker: MTVA returned -44. 7% versus MVIS's -65. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — MTVA or MVIS?
By beta (market sensitivity over 5 years), MetaVia Inc.
(MTVA) is the lower-risk stock at 0. 67β versus MicroVision, Inc. 's 2. 61β — meaning MVIS is approximately 287% more volatile than MTVA relative to the S&P 500. On balance sheet safety, MetaVia Inc. (MTVA) carries a lower debt/equity ratio of 2% versus 66% for MicroVision, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — MTVA or MVIS?
On earnings-per-share growth, the picture is similar: MicroVision, Inc.
grew EPS 23. 9% year-over-year, compared to -44. 7% for MetaVia Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — MTVA or MVIS?
MetaVia Inc.
(MTVA) is the more profitable company, earning 0. 0% net margin versus -78. 6% for MicroVision, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MTVA leads at 0. 0% versus -57. 4% for MVIS. At the gross margin level — before operating expenses — MTVA leads at 0. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — MTVA or MVIS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is MTVA or MVIS better for a retirement portfolio?
For long-horizon retirement investors, MetaVia Inc.
(MTVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 67)). MicroVision, Inc. (MVIS) carries a higher beta of 2. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MTVA: -44. 7%, MVIS: -65. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between MTVA and MVIS?
These companies operate in different sectors (MTVA (Healthcare) and MVIS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.